Estimated pulmonary artery systolic pressure and sickle cell disease: a meta-analysis and systematic review

British Journal of Haematology

Volumn 170, Issue 3, 2015, Pages 416-424

  Caughey, Melissa C ^a   Poole, Charles ^b   Ataga, Kenneth I ^a   Hinderliter, Alan L ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b University of North Carolina at Chapel Hill   (United States)

Author keywords

echocardiography; meta analysis; pulmonary hypertension; sickle cell disease

Indexed keywords

HEMOGLOBIN; HYDROXYUREA; ANTISICKLING AGENT;

BLOOD PRESSURE MEASUREMENT; DATA ANALYSIS; DISEASE ASSOCIATION; ESTIMATED PULMONARY ARTERY SYSTOLIC PRESSURE; GENOTYPE; HUMAN; META ANALYSIS; MORTALITY; OUTCOME ASSESSMENT; PHYSICAL PARAMETERS; PREVALENCE; PRIORITY JOURNAL; REVIEW; SICKLE CELL ANEMIA; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TRICUSPID REGURGITANT VELOCITY; ADULT; ANEMIA, SICKLE CELL; ARTERIAL PRESSURE; ECHOCARDIOGRAPHY; ECHOGRAPHY; FEMALE; MALE; PATHOPHYSIOLOGY; PULMONARY ARTERY;

ADULT; ANEMIA, SICKLE CELL; ANTISICKLING AGENTS; ARTERIAL PRESSURE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; HYDROXYUREA; MALE; PREVALENCE; PULMONARY ARTERY;

EID: 84942092699     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.13447     Document Type: Review

References (61)

1. Abdul-Mohsen, M.F. (2012) Echocardiographic evaluation of left ventricular diastolic and systolic function in Saudi patients with sickle cell disease. Journal of the Saudi Heart Association, 24, 217–224.
2. Adedeji, M.O., Cespedes, J., Allen, K., Subramony, C. & Hughson, M.D. (2001) Pulmonary thrombotic arteriopathy in patients with sickle cell disease. Archives of Pathology & Laboratory Medicine, 125, 1436–1441.
3. Aessopos, A., Farmakis, D., Trompoukis, C., Tsironi, M., Moyssakis, I., Tsaftarides, P. & Karagiorga, M. (2009) Cardiac involvement in sickle beta-thalassemia. Annals of Hematology, 88, 557–564.
4. Agha, H., El Tagui, M., El Ghamrawy, M. & Abdel Hady, M. (2014) The 6-min walk test: an independent correlate of elevated tricuspid regurgitant jet velocity in children and young adult sickle cell patients. Annals of Hematology, 93, 1131–1138.
5. Akgul, F., Yalcin, F., Seyfeli, E., Ucar, E., Karazincir, S., Balci, A. & Gali, E. (2007) Pulmonary hypertension in sickle-cell disease: comorbidities and echocardiographic findings. Acta Haematologica, 118, 53–60.
6. Aleem, A., Jehangir, A., Owais, M., Al-Momen, A., Al-Diab, A., Abdulkarim, H. & Alameri, H. (2007) Echocardiographic abnormalities in adolescent and adult Saudi patients with sickle cell disease. Saudi Medical Journal, 28, 1072–1075.
7. Aliyu, Z.Y., Gordeuk, V., Sachdev, V., Babadoko, A., Mamman, A.I., Akpanpe, P., Attah, E., Suleiman, Y., Aliyu, N., Yusuf, J., Mendelsohn, L., Kato, G.J. & Gladwin, M.T. (2008) Prevalence and risk factors for pulmonary artery systolic hypertension among sickle cell disease patients in Nigeria. American Journal of Hematology, 83, 485–490.
8. Anjum, F., Lazar, J., Zein, J., Jamaleddine, G., Demetis, S. & Wadgaonkar, R. (2012) Characterization of altered patterns of endothelial progenitor cells in sickle cell disease related pulmonary arterial hypertension. Pulmonary Circulation, 2, 54–60.
9. Ataga, K.I., Moore, C.G., Jones, S., Olajide, O., Strayhorn, D., Hinderliter, A. & Orringer, E.P. (2006) Pulmonary hypertension in patients with sickle cell disease: a longitudinal study. British Journal of Haematology, 134, 109–115.
10. van Beers, E.J., Nur, E., Schaefer-Prokop, C.M., Mac Gillavry, M.R., van Esser, J.W., Brandjes, D.P., Kappers-Klunne, M.C., Duits, A.J., Muskiet, F.A., Schnog, J.J., Biemond, B.J. & CURAMA Study Group. (2008) Cardiopulmonary imaging, functional and laboratory studies in sickle cell disease associated pulmonary hypertension. American Journal of Hematology, 83, 850–854.
11. Berger, M., Haimowitz, A., Van Tosh, A., Berdoff, R.L. & Goldberg, E. (1985) Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave Doppler ultrasound. Journal of the American College of Cardiology, 6, 359–365.
12. Billy-Brissac, R., Blanchet-Deverly, A., Etienne-Julan, M. & Foucan, L. (2009) Pulmonary hypertension in an adult sickle cell population in Guadeloupe. International Journal of Cardiology, 135, 122–123.
13. Blanc, J., Stos, B., de Montalembert, M., Bonnet, D. & Boudjemline, Y. (2012) Right ventricular systolic strain is altered in children with sickle cell disease. Journal of the American Society of Echocardiography: Official Publication of the American Society of Echocardiography, 25, 511–517.
14. Cabrita, I.Z., Mohammed, A., Layton, M., Ghorashian, S., Gilmore, A., Cho, G., Howard, J., Anie, K.A., Desforges, L., Bassett, P., Grapsa, J., Howard, L., Mahalingam, G., Dawson, D., Pinto, F.J., Nihoyannopoulos, P., Davies, S.C. & Gibbs, J.S. (2013) The association between tricuspid regurgitation velocity and 5-year survival in a North West London population of patients with sickle cell disease in the United Kingdom. British Journal of Haematology, 162, 400–408.
15. Caldas, M.C., Meira, Z.A. & Barbosa, M.M. (2008) Evaluation of 107 patients with sickle cell anemia through tissue Doppler and myocardial performance index. Journal of the American Society of Echocardiography: Official Publication of the American Society of Echocardiography, 21, 1163–1167.
16. Caughey, M.C., Hinderliter, A.L., Jones, S.K., Shah, S.P. & Ataga, K.I. (2012) Hemodynamic characteristics and predictors of pulmonary hypertension in patients with sickle cell disease. The American Journal of Cardiology, 109, 1353–1357.
17. Chaudry, R.A., Cikes, M., Karu, T., Hutchinson, C., Ball, S., Sutherland, G., Rosenthal, M., Bush, A. & Crowley, S. (2011) Paediatric sickle cell disease: pulmonary hypertension but normal vascular resistance. Archives of Disease in Childhood, 96, 131–136.
18. Colombatti, R., Maschietto, N., Varotto, E., Grison, A., Grazzina, N., Meneghello, L., Teso, S., Carli, M., Milanesi, O. & Sainati, L. (2010) Pulmonary hypertension in sickle cell disease children under 10 years of age. British Journal of Haematology, 150, 601–609.
19. Cox, S.E., Soka, D., Kirkham, F.J., Newton, C.R., Prentice, A.M., Makani, J. & Younoszai, A.K. (2014) Tricuspid regurgitant jet velocity and hospitalization in Tanzanian children with sickle cell anemia. Haematologica, 99, e1–e4.
20. Dahoui, H.A., Hayek, M.N., Nietert, P.J., Arabi, M.T., Muwakkit, S.A., Saab, R.H., Bissar, A.N., Jumaa, N.M., Farhat, F.S., Dabbous, I.A., Bitar, F.F. & Abboud, M.R. (2010) Pulmonary hypertension in children and young adults with sickle cell disease: evidence for familial clustering. Pediatric Blood & Cancer, 54, 398–402.
21. Delclaux, C., Zerah-Lancner, F., Bachir, D., Habibi, A., Monin, J.L., Godeau, B. & Galacteros, F. (2005) Factors associated with dyspnea in adult patients with sickle cell disease. Chest, 128, 3336–3344.
22. Dosunmu, A.O., Balogun, T.M., Adeyeye, O.O., Daniel, F.A., Akinola, R.A., Onakoya, J.A., Akinbami, A.A., Sagoe, A.O. & Onadeko, B.O. (2014) Prevalence of pulmonary hypertension in sickle cell anaemia patients of a tertiary hospital in Nigeria. Nigerian Medical Journal: Journal of the Nigeria Medical Association, 55, 161–165.
23. Eddine, A.C., Alvarez, O., Lipshultz, S.E., Kardon, R., Arheart, K. & Swaminathan, S. (2012) Ventricular structure and function in children with sickle cell disease using conventional and tissue Doppler echocardiography. The American Journal of Cardiology, 109, 1358–1364.
24. Elmariah, H., Garrett, M.E., De Castro, L.M., Jonassaint, J.C., Ataga, K.I., Eckman, J.R., Ashley-Koch, A.E. & Telen, M.J. (2014) Factors associated with survival in a contemporary adult sickle cell disease cohort. American Journal of Hematology, 89, 530–535.
25. El-Shanshory, M., Badraia, I., Donia, A., Abd El-Hameed, F. & Mabrouk, M. (2013) Asymmetric dimethylarginine levels in children with sickle cell disease and its correlation to tricuspid regurgitant jet velocity. European Journal of Haematology, 91, 55–61.
26. Fonseca, G.H., Souza, R., Salemi, V.M., Jardim, C.V. & Gualandro, S.F. (2012) Pulmonary hypertension diagnosed by right heart catheterisation in sickle cell disease. The European Respiratory Journal, 39, 112–118.
27. Forrest, S., Kim, A., Carbonella, J. & Pashankar, F. (2012) Proteinuria is associated with elevated tricuspid regurgitant jet velocity in children with sickle cell disease. Pediatric Blood & Cancer, 58, 937–940.
28. Garrido, V.T., Proenca-Ferreira, R., Dominical, V.M., Traina, F., Bezerra, M.A., de Mello, M.R., Colella, M.P., Araujo, A.S., Saad, S.T., Costa, F.F. & Conran, N. (2012) Elevated plasma levels and platelet-associated expression of the pro-thrombotic and pro-inflammatory protein, TNFSF14 (LIGHT), in sickle cell disease. British Journal of Haematology, 158, 788–797.
29. Gladwin, M.T. & Sachdev, V. (2012) Cardiovascular abnormalities in sickle cell disease. Journal of the American College of Cardiology, 59, 1123–1133.
30. Gladwin, M.T., Sachdev, V., Jison, M.L., Shizukuda, Y., Plehn, J.F., Minter, K., Brown, B., Coles, W.A., Nichols, J.S., Ernst, I., Hunter, L.A., Blackwelder, W.C., Schechter, A.N., Rodgers, G.P., Castro, O. & Ognibene, F.P. (2004) Pulmonary hypertension as a risk factor for death in patients with sickle cell disease. The New England Journal of Medicine, 350, 886–895.
31. Gladwin, M.T., Barst, R.J., Gibbs, J.S., Hildesheim, M., Sachdev, V., Nouraie, M., Hassell, K.L., Little, J.A., Schraufnagel, D.E., Krishnamurti, L., Novelli, E., Girgis, R.E., Morris, C.R., Berman Rosenzweig, E., Badesch, D.B., Lanzkron, S., Castro, O.L., Taylor JG, 6., Goldsmith, J.C., Kato, G.J., Gordeuk, V.R., Machado, R.F. & walk-PHaSST Investigators and Patients. (2014) Risk factors for death in 632 patients with sickle cell disease in the United States and United Kingdom. PLoS One, 9, e99489.
32. Gordeuk, V.R., Minniti, C.P., Nouraie, M., Campbell, A.D., Rana, S.R., Luchtman-Jones, L., Sable, C., Dham, N., Ensing, G., Prchal, J.T., Kato, G.J., Gladwin, M.T. & Castro, O.L. (2011) Elevated tricuspid regurgitation velocity and decline in exercise capacity over 22 months of follow up in children and adolescents with sickle cell anemia. Haematologica, 96, 33–40.
33. Haque, A.K., Gokhale, S., Rampy, B.A., Adegboyega, P., Duarte, A. & Saldana, M.J. (2002) Pulmonary hypertension in sickle cell hemoglobinopathy: a clinicopathologic study of 20 cases. Human Pathology, 33, 1037–1043.
34. Hebson, C., New, T., Record, E., Oster, M., Ehrlich, A., Border, W., James-Herry, A. & Kanaan, U. (2014) Elevated tricuspid regurgitant velocity as a marker for pulmonary hypertension in children with sickle cell disease: less prevalent and predictive than previously thought? Journal of Pediatric Hematology/Oncology, 37, 134–139.
35. Johnson, M.C., Kirkham, F.J., Redline, S., Rosen, C.L., Yan, Y., Roberts, I., Gruenwald, J., Marek, J. & DeBaun, M.R. (2010) Left ventricular hypertrophy and diastolic dysfunction in children with sickle cell disease are related to asleep and waking oxygen desaturation. Blood, 116, 16–21.
36. Kato, G.J., McGowan, V., Machado, R.F., Little, J.A., Taylor, J.6., Morris, C.R., Nichols, J.S., Wang, X., Poljakovic, M., Morris, Jr, S.M. & Gladwin, M.T. (2006) Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood, 107, 2279–2285.
37. Kato, G.J., Hebbel, R.P., Steinberg, M.H. & Gladwin, M.T. (2009) Vasculopathy in sickle cell disease: biology, pathophysiology, genetics, translational medicine, and new research directions. American Journal of Hematology, 84, 618–625.
38. Klings, E.S., Anton Bland, D., Rosenman, D., Princeton, S., Odhiambo, A., Li, G., Bernard, S.A., Steinberg, M.H. & Farber, H.W. (2008) Pulmonary arterial hypertension and left-sided heart disease in sickle cell disease: clinical characteristics and association with soluble adhesion molecule expression. American Journal of Hematology, 83, 547–553.
39. Klings, E.S., Machado, R.F., Barst, R.J., Morris, C.R., Mubarak, K.K., Gordeuk, V.R., Kato, G.J., Ataga, K.I., Gibbs, J.S., Castro, O., Rosenzweig, E.B., Sood, N., Hsu, L., Wilson, K.C., Telen, M.J., Decastro, L.M., Krishnamurti, L., Steinberg, M.H., Badesch, D.B., Gladwin, M.T. & American Thoracic Society Ad Hoc Committee on Pulmonary Hypertension of Sickle Cell Disease. (2014) An official American thoracic society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease. American Journal of Respiratory and Critical Care Medicine, 189, 727–740.
40. Knight-Perry, J.E., de Las Fuentes, L., Waggoner, A.D., Hoffmann, R.G., Blinder, M.A., Davila-Roman, V.G. & Field, J.J. (2011) Abnormalities in cardiac structure and function in adults with sickle cell disease are not associated with pulmonary hypertension. Journal of the American Society of Echocardiography: Official Publication of the American Society of Echocardiography, 24, 1285–1290.
41. Lee, M.T., Small, T., Khan, M.A., Rosenzweig, E.B., Barst, R.J. & Brittenham, G.M. (2009) Doppler-defined pulmonary hypertension and the risk of death in children with sickle cell disease followed for a mean of three years. British Journal of Haematology, 146, 437–441.
42. Liem, R.I., Young, L.T. & Thompson, A.A. (2009) Prolonged QTc interval in children and young adults with sickle cell disease at steady state. Pediatric Blood & Cancer, 52, 842–846.
43. Machado, R.F., Mack, A.K., Martyr, S., Barnett, C., Macarthur, P., Sachdev, V., Ernst, I., Hunter, L.A., Coles, W.A., Nichols, J.P., Kato, G.J. & Gladwin, M.T. (2007) Severity of pulmonary hypertension during vaso-occlusive pain crisis and exercise in patients with sickle cell disease. British Journal of Haematology, 136, 319–325.
44. Marouf, R., Behbehani, N., Zubaid, M., Al Wazzan, H., El Muzaini, H., Abdulla, R., Mojiminiyi, O.A. & Adekile, A.D. (2014) Transthoracic echocardiography and 6-minute walk test in Kuwaiti sickle cell disease patients. Medical Principles and Practice: International Journal of the Kuwait University, Health Science Centre, 23, 212–217.
45. McQuillan, B.M., Picard, M.H., Leavitt, M. & Weyman, A.E. (2001) Clinical correlates and reference intervals for pulmonary artery systolic pressure among echocardiographically normal subjects. Circulation, 104, 2797–2802.
46. Minniti, C.P., Sable, C., Campbell, A., Rana, S., Ensing, G., Dham, N., Onyekwere, O., Nouraie, M., Kato, G.J., Gladwin, M.T., Castro, O.L. & Gordeuk, V.R. (2009) Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation. Haematologica, 94, 340–347.
47. Morris, C.R., Kato, G.J., Poljakovic, M., Wang, X., Blackwelder, W.C., Sachdev, V., Hazen, S.L., Vichinsky, E.P., Morris, Jr, S.M. & Gladwin, M.T. (2005) Dysregulated arginine metabolism, hemolysis-associated pulmonary hypertension, and mortality in sickle cell disease. JAMA, 294, 81–90.
48. Nelson, S.C., Adade, B.B., McDonough, E.A., Moquist, K.L. & Hennessy, J.M. (2007) High prevalence of pulmonary hypertension in children with sickle cell disease. Journal of Pediatric Hematology/Oncology, 29, 334–337.
49. Newcombe, R.G. (1998) Two-sided confidence intervals for the single proportion: comparison of seven methods. Statistics in Medicine, 17, 857–872.
50. Oguanobi, N.I., Ejim, E.C., Anisiuba, B.C., Onwubere, B.J., Ike, S.O., Ibegbulam, O.G. & Agwu, O. (2012) Clinical and electrocardiographic evaluation of sickle-cell anaemia patients with pulmonary hypertension. ISRN Hematology, 2012, 768718.
51. Parent, F., Bachir, D., Inamo, J., Lionnet, F., Driss, F., Loko, G., Habibi, A., Bennani, S., Savale, L., Adnot, S., Maitre, B., Yaici, A., Hajji, L., O'Callaghan, D.S., Clerson, P., Girot, R., Galacteros, F. & Simonneau, G. (2011) A hemodynamic study of pulmonary hypertension in sickle cell disease. The New England Journal of Medicine, 365, 44–53.
52. Pashankar, F.D., Carbonella, J., Bazzy-Asaad, A. & Friedman, A. (2008) Prevalence and risk factors of elevated pulmonary artery pressures in children with sickle cell disease. Pediatrics, 121, 777–782.
53. Riley, R.D., Higgins, J.P. & Deeks, J.J. (2011) Interpretation of random effects meta-analyses. BMJ (Clinical Research Ed.), 342, d549.
54. Rudski, L.G., Lai, W.W., Afilalo, J., Hua, L., Handschumacher, M.D., Chandrasekaran, K., Solomon, S.D., Louie, E.K. & Schiller, N.B. (2010) Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. Journal of the American Society of Echocardiography: Official Publication of the American Society of Echocardiography, 23, 685–713; quiz 786–788.
55. Sachdev, V., Machado, R.F., Shizukuda, Y., Rao, Y.N., Sidenko, S., Ernst, I., St Peter, M., Coles, W.A., Rosing, D.R., Blackwelder, W.C., Castro, O., Kato, G.J. & Gladwin, M.T. (2007) Diastolic dysfunction is an independent risk factor for death in patients with sickle cell disease. Journal of the American College of Cardiology, 49, 472–479.
56. Sachdev, V., Kato, G.J., Gibbs, J.S., Barst, R.J., Machado, R.F., Nouraie, M., Hassell, K.L., Little, J.A., Schraufnagel, D.E., Krishnamurti, L., Novelli, E.M., Girgis, R.E., Morris, C.R., Rosenzweig, E.B., Badesch, D.B., Lanzkron, S., Castro, O.L., Taylor JG, 6., Hannoush, H., Goldsmith, J.C., Gladwin, M.T., Gordeuk, V.R. & Walk-PHASST Investigators. (2011) Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom. Circulation, 124, 1452–1460.
57. Sedrak, A., Rao, S.P., Miller, S.T., Hekmat, V. & Rao, M. (2009) A prospective appraisal of pulmonary hypertension in children with sickle cell disease. Journal of Pediatric Hematology/Oncology, 31, 97–100.
58. Sharma, S., Efird, J., Kadali, R., Mehra, S., Chohan, H., Daggubati, R., Liles, D., Gouge, C., Boettger, P. & Knupp, C. (2013) Pulmonary artery occlusion pressure may overdiagnose pulmonary artery hypertension in sickle cell disease. Clinical Cardiology, 36, 524–530.
59. Tantawy, A.A., Adly, A.A. & Ismail, E.A. (2012) Soluble CD163 in young sickle cell disease patients and their trait siblings: a biomarker for pulmonary hypertension and vaso-occlusive complications. Blood Coagulation & Fibrinolysis: An International Journal in Haemostasis and Thrombosis, 23, 640–648.
60. Voskaridou, E., Tsetsos, G., Tsoutsias, A., Spyropoulou, E., Christoulas, D. & Terpos, E. (2007) Pulmonary hypertension in patients with sickle cell/beta thalassemia: incidence and correlation with serum N-terminal pro-brain natriuretic peptide concentrations. Haematologica, 92, 738–743.
61. Zilberman, M.V., Du, W., Das, S. & Sarnaik, S.A. (2007) Evaluation of left ventricular diastolic function in pediatric sickle cell disease patients. American Journal of Hematology, 82, 433–438.